Tag:

colorectal cancer

Latest Headlines

Latest Headlines

Exact Sciences wins CMS panel vote for Cologuard pricing

Exact Sciences has been working hard to expand reimbursement for its stool-based DNA colorectal cancer test since nabbing Medicare coverage last October, signing on two major private insurers earlier this year. Now the company is celebrating a decision from the Centers for Medicare and Medicaid Services that could lock in Medicare pricing for its test.

Exact Sciences wins CMS panel vote for Cologuard pricing

Exact Sciences has been working hard to expand reimbursement for its stool-based DNA colorectal cancer test since nabbing Medicare coverage last October, signing on two major private insurers earlier this year. Now the company is celebrating a decision from the Centers for Medicare and Medicaid Services that could lock in Medicare pricing for its test.

WSJ: New devices for rectal cancer surgery reduce need for colostomies

New medical devices for rectal cancer surgeries are helping patients forgo colostomies, shifting more individuals toward a new procedure that requires fewer external adjustments, according to medical experts.

Exact Sciences reveals $175M public offering amid Q2 losses

Exact Sciences raked in $175 million in a public offering to dial up development of its stool-based test for colorectal cancer, giving the company a boost as it counters less-than-stellar second-quarter earnings.

Exact Sciences reveals $175M public offering amid Q2 losses

Exact Sciences raked in $175 million in a public offering to dial up development of its stool-based test for colorectal cancer, giving the company a boost as it counters less-than-stellar second-quarter earnings.

Exact Sciences looks beyond colorectal cancer Dx with extended Mayo Clinic collaboration

Exact Sciences is building on a previous collaboration with Mayo Clinic to develop tests for the gastrointestinal tract, riding high off last year's successes and expanding its offerings beyond colorectal cancer.

Exact Sciences looks beyond colorectal cancer Dx with extended Mayo Clinic collaboration

Exact Sciences is building on a previous collaboration with Mayo Clinic to develop tests for the gastrointestinal tract, riding high off last year's successes and expanding its offerings beyond colorectal cancer.

Epigenomics scores Chinese marketing approval for innovative colorectal cancer test

Epigenomics won marketing approval in China for its next-generation colorectal cancer test, moving the company forward on its path toward global commercialization for the product and helping it compete in an increasingly competitive playing field.

Epigenomics scores Chinese marketing approval for innovative colorectal cancer test

Epigenomics won marketing approval in China for its next-generation colorectal cancer test, moving the company forward on its path toward global commercialization for the product and helping it compete in an increasingly competitive playing field.

Exact Sciences nails coveted Medicare coverage for colon cancer DNA test

Exact Sciences now has something that diagnostics companies find increasingly hard to obtain: Medicare coverage, obtained for its new cutting-edge colorectal cancer-screening test.
'